The National Institutes of Health (NIH) is offering a federal grant opportunity for the establishment of an Autoimmune Diseases Statistical and Clinical Coordinating Center (AD-SCCC). This initiative aims to enhance the NIH's mission by providing comprehensive support for clinical study development, regulatory compliance, site monitoring, and biostatistical assistance for clinical trials focused on autoimmune diseases and related areas. The AD-SCCC will play a crucial role in advancing research and collaboration within the field, with an estimated total program funding of $8 million and the expectation of one award. Interested applicants can reach out to Dr. Jeffrey Rice at jeffrey.rice@nih.gov or by phone at 240-627-3552 for further details, with proposals due by June 4, 2026, and the anticipated award date set for March 1, 2027.

The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by establishing an Autoimmune Diseases Statistical &amp; Clinical Coordinating Center (AD-SCCC). The AD-SCCC will provide clinical study development, support domestic and international regulatory requirements, site monitoring, repository management, manuscript production, study archiving, and biostatistical support for ongoing and future clinical trials in the areas of autoimmune diseases, mucosal immunology, and primary immune deficiencies. Additional tasks include collaboration with the Division of Allergy, Immunology and Transplantation (DAIT) Clinical Data and Safety Management Center (CDSMC) and may include support on an emergent basis for other networks and clinical trials within the NIAID mission. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200. 

Buyer

Eligible Applicants

Funding Category

Funding Instrument

Opportunity Category

Cost Sharing or Matching Requirement

Original Source